chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ELEVEN days after vaccination my right upper arm was a little sore at the injection site.  In the morning on the 12th day, January 29, 2021, I have a red, hard, slightly raised welt in the area of the injection site which is a little sore. I would say this is kind of circular and about 3 inches across.  The only effect I had the day  right after the shot was a little soreness and a little redness.  Today the area of the welt is a lot bigger and harder.
A month after vaccine got chest pains upon exertion; and shortness of breath when resting.   Went to Cardiologist and after testing was diagnosed with Coronary Artery Disease Angina. EKG - normal;  Stress Test - normal; CT Scan - to found to have 30% blockage and was possibly causing Angina; Gastro 24 hour PH test and manometry - Esophageal - slow swallow function.
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age and gender (patient identifier: 7613962). On an unspecified date the unspecified patient was administered RECOMBIVAX HB (Lot# H010380, expired date: 18-NOV-2014) dose, frequency, route and location unspecified was stored improperly (first exposed to 9C for 30 minutes and then exposed 8.3C for 1 hour). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
This is a spontaneous report from a contactable consumer (patient). A 24-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EP6955), at the age of 24, via an unspecified route of administration, left arm, Apr 16, 2021, at 10:00, single dose, for COVID-19 immunisation. The patient has no reported medical history. The patient has no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 24, via an unspecified route of administration, left arm, on Mar 26, 2021, at 10:00, single dose, for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 16, 2021, at 21:00, patient experienced fever, headache, nausea, chills and aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of fever, headache, nausea, chills and aches: not resolved (at the time of this report). No follow-up attempts needed. No further information expected.
still got the red, itchy patches after second dose; still got the red, itchy patches after second dose; little bit of arm swelling; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (still got the red, itchy patches after second dose), PRURITUS (still got the red, itchy patches after second dose), PERIPHERAL SWELLING (little bit of arm swelling) and PAIN IN EXTREMITY (arm pain) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 020B21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (amoxicillin) and Allergy to antibiotic (cefzil). Concomitant products included MINERALS NOS, VITAMINS NOS (EQUATE ONE DAILY WOMEN'S HEALTH) from 01-Jan-2017 to an unknown date for an unknown indication.   On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Apr-2021, the patient experienced ERYTHEMA (still got the red, itchy patches after second dose), PRURITUS (still got the red, itchy patches after second dose), PERIPHERAL SWELLING (little bit of arm swelling) and PAIN IN EXTREMITY (arm pain). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 30-Apr-2021, ERYTHEMA (still got the red, itchy patches after second dose), PRURITUS (still got the red, itchy patches after second dose), PERIPHERAL SWELLING (little bit of arm swelling) and PAIN IN EXTREMITY (arm pain) had resolved.            This case was linked to MOD-2021-067349, MOD-2021-067349 (Patient Link).
The patient described having black and blue arm, with severe fever and chills for 3 days.
Pt stated that her left arm was sore, red, swollen, & feverish. From elbow up. Pt went to Emergency Room on 7/28/12, she was diagnosed with cellulitis on her left arm.
Within 24 hrs, experienced severe dizziness, resulting in 2 falls while attempting to stand up.   Also had headache, loss of appetite, and nausea, but the alarming  side effect was the dizziness.  Dizziness also subsided after less than 12 hrs.
Information was received on 13-OCT-2017 from a lawyer regarding a case in litigation concerning a male patient of unknown age. The patient was inoculated with a dose of ZOSTAVAX vaccine on or about 21-SEP-2011 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 14-JAN-2014, the patient was treated by a physician, for the onset of a severe vesicular rash accompanied by weakened immune systems, which was diagnosed as severe herpes zoster, or shingles. The patient has ben prescribed acyclovir (manufacturer unknown) for management of his painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages. and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
12/23/2022 I was bitten by a dog and treated by same doctor. Doctor cleaned wound and gave VOLTAREN for inflammation. That day I started to develop symptoms of fever and a runny nose, coughing, sinus pressure, headache, joint pain more than normal, typically it's just knees and hips, this was all joints from ankles to neck up the spin, along with diarrhea, Skin hurt as well, chills, stomach pain. 12/26 positive on an at home COVID-19 test. Televisit with doctor on 12/27. Doctor prescribed PAXLOVID and to treat symptomatically. While on PAXLOVID, mucus changed viscosity from thick and gloopy to thin and runny, I developed a sore throat, the diarrhea was bad, and diminished appetite. On 1/1/2023 symptoms diminished to just the runny nose and mild cough.  Then on 1/5 symptoms returned with greater volume of thick gloopy mucus, sinus pressure, headache, stomachache, joint pain, fever was worse than before with increased sweating that would necessitate changing of clothes multiple times a day, and diarrhea returned as well. During rebound, there was no skin sensitivity, but the rash was worse and itchy. Doctor advised this might be "Covid Rebound" by email and to treat symptomatically. Second time around, the symptoms were much worse with dizziness and brain fog developing. Doctor prescribed a second round of PAXLOVID. Symptoms gradually getting better starting on 2/6/2023 until finally ending on 2/12/2023. Participant reports they have had 3 colds between 2/12/2023 and time of reporting.
Vaccine was administered and about 3 minutes after administration the patient said she felt dizzy and then had a syncopal episode lasting less than one minute.  The patient was already seated but I supported her weight so she did not fall out of the chair.  Dr. was immediately notified and came to the exam room.  Once the patient was able, she was assisted to the exam table to lay down and Dr. assessed her (pulse, orienteation); patient was oriented and pulse was normal.  We kept her in the room for 25 minutes for observation and her condition improved after about 15 minutes, and she was sitting up, drinking water and talking with her siblings and mother.
Immediately following the injection of vaccines and post the Depo injection the client had a syncopal episode - patient was unable to communicate, eyes rolled back and fluttered per RN. The RN observed some tremors/twitching in hands. Client was seated at the time. The entire episode lasted less than 30 seconds.  Her vital signs were within normal limits.  She was monitored for 20 minutes before leaving the clinic with her Mom. Mom called the clinic on 6/11/19 to report that pt continued to have difficulties with muscle twitching, weakness and not being able to stand on her own. She described it as "seizure-like" activity. She called an Urgent Care that referred her to the Emergency Room. The ER stated a 6-8 hour wait so mom contacted pt's PCP. The PCP stated that pt should tak Ibuprofen, check her blood pressure and temperature. Mom reported that pt was afebrile, her BP was elevated with a systolic of 142. Her neuro/muscular symptoms resolved over night and mom reports that pt is feeling better this morning. She has a follow up visit with her PCP on Friday.
Patient states that 5 hours after receiving 2nd dose of Moderna she hemorrhaged.  Patient has subsequently developed "blood cancer" as stated by patient after receiving 2nd Moderna vaccine.  No documentation of hospital visit for hemorrhage can be obtained by this reporter but there was documentation by an ENT visit for the patient looking for medical clearance for surgery after having epistaxis where it states that the patient began experiencing nose bleeds after the second vaccine.  Patient was also seen at the end of March for TIA and has known carotid artery disease.
cont crying-inconsolable approx 3hr p/vax given & duration 6hr;APAP given;+redness/tenderness involving entire thigh where immunization given;
This spontaneous report as received from a pharmacist refers to a female patient of unknown age who on 30-JAN-2013 was vaccinated with a 0.5 ml dose of M-M-R II subcutaneously (anatomical location was not provided) lot number reported as H0125569. On 02-FEB2013, the patient experienced a headache, her body was warm all over and she had not appetite. The patient visited to physician and was diagnosed with lymphadenopathy. The patient was treated with unspecified steroids. The outcome of lymphadenopathy was unknown. The relatedness for lymphadenopathy was unknown for M-M-R II. Additional information is not expected. This is one of several reports received from the same source.
Outcome: Missed work Symptoms: Hot & cold Chills Headache Nausea Exhaustion Swollen & red arm Pain at injection sight
Arm was sore; Every time I bend over, I'm little dizzy; Bad headache yesterday; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), DIZZINESS (Every time I bend over, I'm little dizzy) and HEADACHE (Bad headache yesterday) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore), DIZZINESS (Every time I bend over, I'm little dizzy) and HEADACHE (Bad headache yesterday). At the time of the report, PAIN IN EXTREMITY (Arm was sore), DIZZINESS (Every time I bend over, I'm little dizzy) and HEADACHE (Bad headache yesterday) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided for the second dose.   This case was linked to MOD-2021-032387.
Patient c/o chest pain within 10 min of receiving vaccine.  On exam reproducible costochondritis  HR, RR, Pox - normal  Offered dose of motrin/water 5 min post medication - reports less discomfort.
Stayed for 25 minutes for observation and told to call in 24 hours. Sore arm
6 blister like papules noted on right thigh and 2 on right arm, pruritic.
MOM STATES CHILD BEGAN WITH RASH RIGHT CHEEK & BOTH CHEEKS SWOLLEN APPROXIMATELY 1/2 HOUR AFTER IMMUNIZATIONS GIVEN. THE NEXT MORNING (3/4)CHILD WOKE WITH RASH BOTH CHEEKS AND FACE STILL SLIGHTLY SWOLLEN ALL OVER.  CHILD HAD APPOINTMENT WITH ENT FOR PREVIOUS SINUS PROBLEMS THAT AM.  DR. STATED HER THROAT WAS ALSO SLIGHTLY SWOLLEN.  AFTER DR. APPOINTMENT CHILD SPIKED A FEVER OF 101.8.  CHILD TAKEN TO ER AND WAS GIVEN BENADRYL AND MEDICATION FOR FEVER AND SENT HOME.  FRIDAY MORNING (3/5) CHILD WOKE WITH COUGH AND C/O TROUBLE BREATHING.  MOM CALLED 911 AND WAS GIVEN BREATHING TREATMENT AS PULSE OX WAS ONLY 86 AND TRANSPORTED TO HOSPITAL. PHYSICIAN STATED CONDITION RELATED TO ANTIBIOTIC CHILD HAD BEEN ON (SULFAMETHOXAZOLE).  MOM SPOKE WITH FAMILY PHYSICIAN WHO PUT CHILD ON PEDIAPRED FOR 3 DAYS AND INCREASED HER ZYRTEC (WHICH SHE HAS BEEN ON FOR QUITE A WHILE).
4yo; got orange vaccine first shot  (6/23/22) and maroon second shot (7/19/22)  called family with this guidance: Children ages 6 months?4 years who receive different mRNA products for the first 2 doses of an mRNA COVID-19 vaccine series should follow a 3-dose schedule. A third dose of either mRNA vaccine should be administered 8 weeks after the second dose to complete the 3-dose primary series. Family states they will call scheduling for third dose.
Patient received Covid dose 2 lot number FJ8757 on 2/2/2022. Vaccine expired 1/15/2022. Email sent to provider to contact patient.
I started itching on my elbows, legs, rear./break out in hives; driving me crazy; This is a spontaneous report from a contactable consumer or other non hcp.   A 50-years-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EL3249 expiry date was not reported), first dose , single via an unspecified route in the right arm on an 21Jan2021 at 06:30 AM as a single dose and dose 2 via an unspecified route of administration, at Arm Right on 12Feb2021 06:00 (Lot Number: EL9269, expiry date was not reported) as a SINGLE DOSE for covid-19 immunisation. The patient's concomitant medications were not reported. The patient had Known allergies Sulfa. The patient did not have covid prior vaccination. The patient did not covid tested post vaccination. On 20Feb2021 08:15 the patient experienced itching on patient elbows, legs, rear, break out in hives, (driving me crazy (feeling abnormal) the outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
Recd. 3 Vaccines-TDAP, Varicella, MCV4, in Health Clinic. Had received same vaccines in another clinic 5 days apart, not in his original record, found in system, after the vaccines was given.
Patient had a rash on his back and chest for two months following the tetanus shots. The doctors believed it to be an allergic reaction, dermatitis. We followed doctor recommendations and tried hydrocortisone and two different oral antihistamines, but these did not seem to make any difference. We tried eliminating things from his diet to no avail. Then, finally, after 2 months, it went away on its own. The doctors were very clear that they did not suspect it was from the vaccines when I asked, but my husband and I felt it was a big "coincidence" that the timing of this unexplained rash was directly following these two shots. Patient is unvaccinated otherwise.
left skin pigmentation very dark, dark brown, almost like a sunburn; reaction in the arm where vaccine was injected; very hot; very red; Patient will not get 2nd dose as HCP recommended; tremors in the legs; tremors in the legs have been gradually getting worse; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (tremors in the legs), PIGMENTATION DISORDER (left skin pigmentation very dark, dark brown, almost like a sunburn), VACCINATION SITE REACTION (reaction in the arm where vaccine was injected), VACCINATION SITE WARMTH (very hot ) and CONDITION AGGRAVATED (tremors in the legs have been gradually getting worse) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included LEVOTHYROXINE and VITAMINS NOS for an unknown indication.    On 02-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Sep-2021, the patient experienced TREMOR (tremors in the legs), CONDITION AGGRAVATED (tremors in the legs have been gradually getting worse) and PRODUCT DOSE OMISSION ISSUE (Patient will not get 2nd dose as HCP recommended). On an unknown date, the patient experienced PIGMENTATION DISORDER (left skin pigmentation very dark, dark brown, almost like a sunburn), VACCINATION SITE REACTION (reaction in the arm where vaccine was injected), VACCINATION SITE WARMTH (very hot ) and VACCINATION SITE ERYTHEMA (very red). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, TREMOR (tremors in the legs), PIGMENTATION DISORDER (left skin pigmentation very dark, dark brown, almost like a sunburn) and CONDITION AGGRAVATED (tremors in the legs have been gradually getting worse) had not resolved and VACCINATION SITE REACTION (reaction in the arm where vaccine was injected), VACCINATION SITE WARMTH (very hot ), VACCINATION SITE ERYTHEMA (very red) and PRODUCT DOSE OMISSION ISSUE (Patient will not get 2nd dose as HCP recommended) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.
Later in the day on 11/17, patient developed a diffuse urticarial rash.  That evening, had chills/shaking and muscle aches all over.  Felt better the next day,  but then developed a diffuse urticarial rash.
Headache, muscle aches, chills all the day following the injection and some the day after that
pt recvd vax; ha, abdo pain; redness, pain, itching at site p/ dsoe 1; redness, itching at site p/ dose 2; tx w/ ibuprophen dose 2;
Patient received Pneumovax 23 last year in September. He came in this year to get his next pneumonia shot and was given another Pneumonia 23 instead of Prevnar 13. Patient stated today (10-2-19) that his arm started to swell Sunday evening, got worse Monday, then started to get better on Tuesday. I advised him to call his doctor. I also called his doctor and spoke with employee. She gave the information to the doctor and said they will follow up with the patient. Patient already had an appointment scheduled for Friday, 10-4-19 prior to this event.
pt brought to ED via EMS due to being less responsive than normal; found to have elevated ammonia levels, AKI, lactic acidosis; left hydropneumothorax; during hospital stay, pt tested positive for COVID and passed away the following day
COMES IN FOR ACUTE VISIT FOR RASH REACTION AFTER HER SECOND COVID VACCINE.   HAD FATIGUE X 2 DAYS, NO OTHER SX FROM VACCINE EXCEPT REACTION AT ARM THAT SHE IS CONCERNED ABOUT SINCE IT IS MOVING DOWN AND AROUND HER ARM. STARTED WITH REDNESS DAY AFTER VACCINE, LEFT UPPER ARM AT SHOULDER AREA. THEN NEXT DAY  MOVED DOWN TO MID ARM AND THEN YESTERDAY AND TODAY MORE AT MID ARM EXTENDING TO MEDIAL ARM. THE REDNESS AT SHOULDER AREA AND NEAR SHOULDER HAS RESOLVED. NOT REALLY PAINFUL, MORE JUST A LITTLE IRRITATED/ A LITTLE ITCHY. NO PAIN IN MUSCLE, GOOD ROM SHOULDERS. NO LUMP NOTICED AT ARMPIT.
Rash/hive developed on ankles, legs first.  Spread to waist, chest, by 9PM same day.  09/29/14 0500 AM - spread to arms, wrist and palm of hands. Red dots varying between 1/16" and 1/4" diameter. Itching accompanies rash/hives.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Nausea-Severe, Systemic: Vomiting-Severe, Additional Details: Patient's wife called morning of 11/20 (2 days after he received vaccines) stating her husband felt very dizzy to the point of extreme nausea and constant vomiting.
This case was reported by a consumer via call center representative and described the occurrence of lethargic in a 63-year-old female patient who received SHINGRIX for prophylaxis. In March 2018, the patient received the 1st dose of Shingrix. In March 2018, 1 day after receiving SHINGRIX, the patient experienced lethargic and pain. On an unknown date, the outcome of the lethargic and pain were recovered/resolved. The reporter considered the lethargic and pain to be almost certainly related to SHINGRIX. Additional details were provided as follows: The patient received Shingrix on left arm. Next day, after vaccination the patient experienced lethargic and achy. This case has been linked with US2018GSK106673, reported by the same reporter for 2nd dose.
After receiving the flu vaccination on 10/03/2020 I felt extremely tired, symptoms started appearing such as a rash with hives, nausea, dizziness. The hive like rash was over a good portion of my body especially on thighs and arms.  On 10/15/2020 I went to a healthcare office and received treatment for an allergic reaction to the vaccination. On the day I received treatment injection site was still painful to the touch, and injection site was still noticeable to doctor from 6 feet away.  I still of course have on going reaction.
Redness at site, pain 5/10, red, raised indurated itchy 50 mm diameter. Systemic, feels "sick" joint aches, nausea, cramping yesterday in abdomen and lower back - now sore. Temp not taken. Dizzy.
ZOSTAVAX administered on 4/27/12. Patient developed s/s of shingles on 5/4/12. Painful rash on (R) arm. Treatment with acyclovir initiated on 5/4/12.
this is one of four patients to devel an inj site rxn characterized by pain, swelling, & redness p/vax;pt recovered p/being treated w/DPH & Celestone inj;
Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Rash, fever, petechiae--scattered throughout body; pruritic lesions. 1 hour after shots started fever, fussy. Woke up during night noted a fever and spots scattered throughout body. Meningococcemia.
I woke up feeling facial numbness and paresthesia on the left side of my face from my scalp down to my upper lip.  I had no facial drooping nor muscle weakness.  Just numbness and pins and needles.  The numbness continues today however the area of numbness has decreased and is now centered around my cheekbone and upper jaw. It still is only the left side of face.